New At-Home Celiac Disease Research Study
Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingConsider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue ReadingConsider joining the LILY Study, a phase 1 clinical trial for people with celiac disease investigating DONQ52, a new potential celiac disease treatment.
Continue ReadingiCureCeliac® is the Foundation’s patient-powered tool that is the single best resource for celiac disease researchers around the world helping to accelerate the search for treatments and a cure.
Continue ReadingThe risk of developing CAD in celiac patients was found to be higher for white males, and patients with celiac disease and CAD are more likely to have disorders such as high cholesterol, type 2 diabetes, and iron-deficiency anemia.
Continue ReadingLast week in Washington, D.C., the Celiac Disease Foundation and our allies secured two critical wins in our mission to drive policy change to improve the health of those living with celiac disease.
Continue ReadingNew research studying the association of celiac disease and inflammatory bowel disease (IBD) shows a strong relationship between the two conditions.
Continue ReadingCuring Celiac: A Short Story, a new film by Hayley Repton, encourages patients to join the iCureCeliac® patient registry, the single best patient-centered resource for celiac disease researchers in the world.
Continue ReadingAn analysis by an independent statistician of the ongoing Phase 3 trial for Larazotide has concluded that a substantial number of new patients would have to be added to the existing trial in order to get scientifically meaningful results.
Continue ReadingLast week, the Celiac Disease Foundation, as part of The Defense Health Research Consortium, co-signed a letter requesting a budget increase for the Congressionally Directed Medical Research Programs.
Continue ReadingThe FDA released the long-awaited draft guidance, “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet."
Continue Reading